Dr Kostas Stamatopoulos on his research and patient empowerment work
Providing novel treatments and standardising CLL biomarker testing across the world
Navigating advances in the myeloma landscape over the past couple of years
Bispecific agents: the future of AML and MDS treatment?
Prophylactic treatment for CAR T-cell toxicity shows promising results